VALIDOL AVEXIMA
- Registration number:ЛСР-010613/09
- International non-proprietary name:levomenthol + dextrose
- Pharmaceutical form:sublingual tablets
- Pharmacotherapeutic group:coronary dilating drug with reflex action
- Dosage form:sublingual tablets No. 20
- Composition:levomenthol solution in menthyl isovalerate (Validol) - 60 mg, dextrose monohydrate (glucose monohydrate) - 188 mg
VALIDOL AVEXIMA produces a sedating effect, it has a moderate reflex vasodilatory action mediated by irritation of nerve endings. It stimulates production and release of enkephalins, endorphins, and a range of other peptides, kinins, which actively participate in regulation of vascular permeability, generation of pain sensation.
Information for patients with diabetes mellitus: 1 tablet corresponds to 0.054 bread unit.-
Indications for use:
• functional cardialgias;
• neuroses;
• antiemetic agent in sea and air sickness.
- Manufacturer
- OJSC "Irbitsky Chemical-Pharmaceutical Plant"
Sublingually, keep in the mouth until complete dissolution.
For adults, 1 tablet 2-3 times daily.
Daily frequency and duration of intake are determined based on the treatment efficacy.
Shelf life
is 2 years. Do not use after the expiry date.
We recommend
-
antiviral agent, aciclovir
-
Combination drug
-
Antiviral drug
-
Antiepileptic agent
-
Spasmolytic agent
-
-
-
-
Antimicrobial agent
-
Antimicrobial agent
-
Combination drug
-
-
Antimicrobial and antiprotozoal agent
-
Antimicrobial agent
-
Coronary dilating drug
-
Antimicrobial agent
-
Antimicrobial and antiprotozoal agent.
-
Enzyme product
-
Calcium channel blocker
-
Analgesic agent
-
Antifungal agent
-
-
Antimicrobial agent
-
NOBAZIT®
-
-
Enterosorbent.
-
Non-steroidal anti-inflammatory drug (NSAID)
-
Potassium and magnesium preparation
-
Combination antimicrobial agent
-
Antifungal agents
-
-
Antifungal agent
-
Metabolic agent